Farmaceutica (Romania) Price Prediction
| RMAH Stock | 0.89 0.02 2.30% |
Momentum 82
Buy Peaked
Oversold | Overbought |
Using Farmaceutica hype-based prediction, you can estimate the value of Farmaceutica R from the perspective of Farmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Farmaceutica to buy its stock at a price that has no basis in reality. In that case, they are not buying Farmaceutica because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Farmaceutica after-hype prediction price | RON 0.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Farmaceutica |
Farmaceutica Estimiated After-Hype Price Prediction Volatility
As far as predicting the price of Farmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Farmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Farmaceutica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Farmaceutica Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Farmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Farmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Farmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 1.71 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.89 | 0.89 | 0.00 |
|
Farmaceutica Hype Timeline
Farmaceutica R is at this time traded for 0.89on Bucharest Stock Exchange of Romania. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Farmaceutica is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.47%. %. The volatility of related hype on Farmaceutica is about 0.0%, with the expected price after the next announcement by competition of 0.89. The company had not issued any dividends in recent years. Assuming the 90 days trading horizon the next estimated press release will be within a week. Check out Farmaceutica Basic Forecasting Models to cross-verify your projections.Farmaceutica Related Hype Analysis
Having access to credible news sources related to Farmaceutica's direct competition is more important than ever and may enhance your ability to predict Farmaceutica's future price movements. Getting to know how Farmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Farmaceutica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DIGI | Digi Communications NV | 0.00 | 0 per month | 0.91 | 0.23 | 3.18 | (1.88) | 8.83 | |
| AROBS | AROBS TRANSILVANIA SOFTWARE | 0.00 | 0 per month | 0.84 | 0.07 | 2.74 | (1.49) | 8.43 | |
| TRANSI | TRANSILVANIA INVESTMENTS ALLIANCE | 0.00 | 0 per month | 1.16 | 0.13 | 3.92 | (1.96) | 8.08 | |
| EVER | Evergent Investments SA | 0.00 | 0 per month | 1.04 | 0.23 | 3.64 | (2.04) | 9.91 | |
| HUNT | IHUNT TECHNOLOGY IMPORT EXPORT | 0.00 | 0 per month | 1.28 | 0.11 | 3.45 | (3.33) | 22.80 |
Farmaceutica Additional Predictive Modules
Most predictive techniques to examine Farmaceutica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Farmaceutica using various technical indicators. When you analyze Farmaceutica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Farmaceutica Predictive Indicators
The successful prediction of Farmaceutica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Farmaceutica R, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Farmaceutica based on analysis of Farmaceutica hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Farmaceutica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Farmaceutica's related companies.
Pair Trading with Farmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Farmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Farmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving together with Farmaceutica Stock
Moving against Farmaceutica Stock
| 0.75 | ALT | Altur Slatina | PairCorr |
| 0.65 | ALU | Alumil Rom Industry | PairCorr |
| 0.58 | ALR | Alro Slatina | PairCorr |
| 0.57 | ARTE | Artego Tg Jiu | PairCorr |
The ability to find closely correlated positions to Farmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Farmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Farmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Farmaceutica R to buy it.
The correlation of Farmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Farmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Farmaceutica R moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Farmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Farmaceutica Stock
Farmaceutica financial ratios help investors to determine whether Farmaceutica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Farmaceutica with respect to the benefits of owning Farmaceutica security.